Peyman Akhavan, Maryam Dehghani, Amir Rajabpour and Amir Pezeshkan
This paper aims to explore the relationship between personality traits (introversion versus extroversion) and knowledge acquisition (KA) techniques.
Abstract
Purpose
This paper aims to explore the relationship between personality traits (introversion versus extroversion) and knowledge acquisition (KA) techniques.
Design/methodology/approach
The major methodology of the current study is survey. Results are based on 152 usable responses provided by experts in different industries including electronic, communication, information technology, computer and biology. The major analytical technique used is Pearson correlation analysis.
Findings
According to the results, there are significant relationships between personality traits (i.e. introversion versus extroversion) and KA techniques.
Research limitations/implications
This study was conducted on data from 152 Iranian experts which limits the generalizability of the results. This limitation can be addressed by future studies conducting similar studies on cross-country samples. Further, due to the analytical technique adopted in this study, causality implications cannot be drawn from the results.
Originality/value
This study reveals linkages between personality traits (i.e. introversion versus extroversion) and KA techniques. Results shed light on the KA process for both scholars and practitioners involved in KA programs in the organizations.
Details
Keywords
Mahsa Khodadoostan, Majid Aghadavood Marnani, Amir Reza Moravejolahkami, Gholamreza Askari and Bijan Iraj
Today, coronavirus disease-19 (COVID-19) treatment is an evolving process, and synbiotic administration has been suggested as a new therapeutic strategy. This study aims to…
Abstract
Purpose
Today, coronavirus disease-19 (COVID-19) treatment is an evolving process, and synbiotic administration has been suggested as a new therapeutic strategy. This study aims to investigate the effect of synbiotic supplementation in COVID-19 patients.
Design/methodology/approach
In this placebo-controlled trial, 80 patients were randomized to receive oral synbiotic capsule (containing fructooligosaccharide and seven bacterial strains; Lactobacillus (L) casei, L. rhamnosus, Streptococcus thermophilus, Bifidobacterium breve, L. acidophilus, Bifidobacterium longum, L. bulgaricus, each one 109 colony-forming units) or placebo for two months. Inflammatory markers (Interleukin-6 [IL-6], C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) and white blood cell (WBC) count were evaluated at two timepoints (baseline, two months later). The measured variables were adjusted for confounders and analyzed by SPSS v21.0.
Findings
All 80 enrolled patients completed the study. The study adherence was good (approximately 70%). The mean changes for IL-6 were not significant (Δ = −0.6 ± 10.4 pg/mL vs Δ = +11.2 ± 50.3 pg/mL, p > 0.05). There were no significant improvements for CRP, ESR and WBC.
Originality/value
Administration of synbiotics for two months did not improve inflammatory markers in COVID-19 patients.